OBJECTIVES: New anti-mycobacterial entities with novel mechanisms of action are clinically needed for treating resistant forms of tuberculosis. The purpose of this study was to evaluate anti-tubercular activity and selectivity of seven recently isolated natural products from Colombian plants. METHODS: MICs were determined using a liquid medium growth inhibition assay for Mycobacterium tuberculosis H(37)Rv and both solid and liquid media growth inhibition assays for Mycobacterium bovis BCG. Escherichia coli growth inhibition and mammalian macrophage cell toxicity were evaluated to establish the degree of selectivity of the natural product against whole cell organisms. Enzymatic inhibition of ATP-dependent MurE ligase from M. tuberculosis was assayed using a colorimetric phosphate detection method. The most active compound, 3-methoxynordomesticine hydrochloride, was further investigated on M. bovis BCG for its inhibition of sigmoidal growth, acid-fast staining and viability counting analysis. RESULTS: Aporphine alkaloids were found to be potent inhibitors of slow-growing mycobacterial pathogens showing favourable selectivity and cytotoxicity. In terms of their endogenous action, the aporphine alkaloids were found inhibitory to M. tuberculosis ATP-dependent MurE ligase at micromolar concentrations. A significantly low MIC was detected for 3-methoxynordomesticine hydrochloride against both M. bovis BCG and M. tuberculosis H(37)Rv. CONCLUSIONS: Considering all the data, 3-methoxynordomesticine hydrochloride was found to be a potent anti-tubercular compound with a favourable specificity profile. The alkaloid showed MurE inhibition and is considered an initial hit for exploring related chemical space.
OBJECTIVES: New anti-mycobacterial entities with novel mechanisms of action are clinically needed for treating resistant forms of tuberculosis. The purpose of this study was to evaluate anti-tubercular activity and selectivity of seven recently isolated natural products from Colombian plants. METHODS: MICs were determined using a liquid medium growth inhibition assay for Mycobacterium tuberculosis H(37)Rv and both solid and liquid media growth inhibition assays for Mycobacterium bovis BCG. Escherichia coli growth inhibition and mammalian macrophage cell toxicity were evaluated to establish the degree of selectivity of the natural product against whole cell organisms. Enzymatic inhibition of ATP-dependent MurE ligase from M. tuberculosis was assayed using a colorimetric phosphate detection method. The most active compound, 3-methoxynordomesticine hydrochloride, was further investigated on M. bovis BCG for its inhibition of sigmoidal growth, acid-fast staining and viability counting analysis. RESULTS:Aporphine alkaloids were found to be potent inhibitors of slow-growing mycobacterial pathogens showing favourable selectivity and cytotoxicity. In terms of their endogenous action, the aporphine alkaloids were found inhibitory to M. tuberculosisATP-dependent MurE ligase at micromolar concentrations. A significantly low MIC was detected for 3-methoxynordomesticine hydrochloride against both M. bovis BCG and M. tuberculosis H(37)Rv. CONCLUSIONS: Considering all the data, 3-methoxynordomesticine hydrochloride was found to be a potent anti-tubercular compound with a favourable specificity profile. The alkaloid showed MurE inhibition and is considered an initial hit for exploring related chemical space.
Authors: Sandeep Chaudhary; Shashikanth Ponnala; Onica Legendre; Junior A Gonzales; Hernán A Navarro; Wayne W Harding Journal: Bioorg Med Chem Date: 2011-08-18 Impact factor: 3.641
Authors: Juan D Guzman; Dimitrios Evangelopoulos; Antima Gupta; Kristian Birchall; Solomon Mwaigwisya; Barbara Saxty; Timothy D McHugh; Simon Gibbons; John Malkinson; Sanjib Bhakta Journal: BMJ Open Date: 2013-06-20 Impact factor: 2.692
Authors: Juan David Guzman; Abraham Wube; Dimitrios Evangelopoulos; Antima Gupta; Antje Hüfner; Chandrakala Basavannacharya; Md Mukhleshur Rahman; Christina Thomaschitz; Rudolf Bauer; Timothy Daniel McHugh; Irene Nobeli; Jose M Prieto; Simon Gibbons; Franz Bucar; Sanjib Bhakta Journal: J Antimicrob Chemother Date: 2011-05-28 Impact factor: 5.790
Authors: Juan D Guzman; Thomas Pesnot; Diana A Barrera; Heledd M Davies; Eleanor McMahon; Dimitrios Evangelopoulos; Parisa N Mortazavi; Tulika Munshi; Arundhati Maitra; Eleanor D Lamming; Richard Angell; Markus C Gershater; Joanna M Redmond; Deborah Needham; John M Ward; Luis E Cuca; Helen C Hailes; Sanjib Bhakta Journal: J Antimicrob Chemother Date: 2015-02-04 Impact factor: 5.790
Authors: Tulika Munshi; Antima Gupta; Dimitrios Evangelopoulos; Juan David Guzman; Simon Gibbons; Nicholas H Keep; Sanjib Bhakta Journal: PLoS One Date: 2013-03-21 Impact factor: 3.240